bromodeoxyuridine has been researched along with Carotid Artery Diseases in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (50.00) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hong, KW; Kim, CD; Lee, JH; Lee, WS; Park, SY; Shin, HK | 1 |
Bi, X; Fang, S; He, J; Kong, J; Li, XM; Tan, Q; Yan, B; Zhang, D; Zhang, Y; Zhang, Z | 1 |
Abe, J; Kurokawa, K; Ohno, M; Schwartz, SM; Taguchi, J | 1 |
Dell'Acqua, G; Dzau, VJ; Ehsan, A; Mann, MJ | 1 |
Betz, E; Hanke, H; Karsch, KR; Oberhoff, M; Strohschneider, T | 1 |
Betz, E; Haase, KK; Hanke, H; Hanke, S; Hassenstein, S; Karsch, KR; Oberhoff, M | 1 |
6 other study(ies) available for bromodeoxyuridine and Carotid Artery Diseases
Article | Year |
---|---|
Cilostazol preserves CA1 hippocampus and enhances generation of immature neuroblasts in dentate gyrus after transient forebrain ischemia in rats.
Topics: Analysis of Variance; Animals; Brain Ischemia; Bromodeoxyuridine; Carotid Artery Diseases; Cell Survival; Cilostazol; Cyclic AMP Response Element-Binding Protein; Disease Models, Animal; Doublecortin Domain Proteins; Doublecortin Protein; Fluoresceins; Hippocampus; Microtubule-Associated Proteins; Neurogenesis; Neurons; Neuropeptides; Neuroprotective Agents; Organic Chemicals; Phosphopyruvate Hydratase; Rats; Tetrazoles; Time Factors | 2009 |
Quetiapine prevents oligodendrocyte and myelin loss and promotes maturation of oligodendrocyte progenitors in the hippocampus of global cerebral ischemia mice.
Topics: Analysis of Variance; Animals; Antigens; Antipsychotic Agents; Brain Ischemia; Bromodeoxyuridine; Carotid Artery Diseases; Cell Differentiation; Dibenzothiazepines; Disease Models, Animal; Gene Expression Regulation; Glial Fibrillary Acidic Protein; Hippocampus; Male; Mice; Myelin Basic Protein; Myelin Sheath; Oligodendroglia; Proteoglycans; Quetiapine Fumarate; Time Factors | 2012 |
Topical application of AT1 receptor antagonists prevents medial and neointimal proliferation after balloon injury.
Topics: Administration, Oral; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Arginine; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Bromodeoxyuridine; Carotid Artery Diseases; Carotid Artery, Common; Catheterization; Cell Division; Drug Synergism; Imidazoles; Losartan; Male; Muscle, Smooth, Vascular; Rats; Rats, Wistar; Tetrazoles; Tunica Intima; Tunica Media | 1994 |
Long-term stabilization of vein graft wall architecture and prolonged resistance to experimental atherosclerosis after E2F decoy oligonucleotide gene therapy.
Topics: Anastomosis, Surgical; Animals; Antimetabolites; Arteriosclerosis; Bromodeoxyuridine; Carotid Artery Diseases; Carotid Artery, Common; Carrier Proteins; Cell Cycle Proteins; Cell Division; Cholesterol, Dietary; Disease Progression; DNA Probes; DNA-Binding Proteins; E2F Transcription Factors; Genetic Therapy; Hypertrophy; Jugular Veins; Muscle, Smooth, Vascular; Proliferating Cell Nuclear Antigen; Rabbits; Retinoblastoma-Binding Protein 1; Transcription Factor DP1; Transcription Factors; Transfection; Tunica Intima; Up-Regulation | 2001 |
Time course of smooth muscle cell proliferation in the intima and media of arteries following experimental angioplasty.
Topics: Angioplasty, Balloon; Animals; Antibodies, Monoclonal; Arteries; Arteriosclerosis; Bromodeoxyuridine; Carotid Artery Diseases; Cell Division; DNA; Fluorescent Antibody Technique; Histological Techniques; Male; Muscle, Smooth, Vascular; Rabbits; Staining and Labeling; Time Factors | 1990 |
Morphological changes and smooth muscle cell proliferation after experimental excimer laser treatment.
Topics: Angioplasty, Laser; Animals; Bromodeoxyuridine; Carotid Arteries; Carotid Artery Diseases; DNA; Hyperplasia; Intracranial Arteriosclerosis; Male; Muscle, Smooth, Vascular; Rabbits; Recurrence; Time Factors | 1991 |